Blonde, L., Rosenstock, J., Frias, J., Birkenfeld, A. L., Niemoeller, E., Souhami, E., . . . Aroda, V. R. (2021). Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. Diabetes Care.
Styl ChicagoBlonde, Lawrence, Julio Rosenstock, Juan Frias, Andreas L. Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, a Vanita R. Aroda. "Durable Effects of IGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study." Diabetes Care 2021.
Citace podle MLABlonde, Lawrence, et al. "Durable Effects of IGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study." Diabetes Care 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..